Editors' Message

Welcome to the 65th annual meeting of the American Society of Hematology. In addition to meeting friends and colleagues old and new, forging collaborations, and learning of the promising new advances in hematology, we hope you will discover that this year’s meeting will not just meet but exceed the high standards for education for which the ASH Education Program is known. With a complete set of rigorously peer-reviewed, case-based, concise articles for this year’s education program replete with useful figures and tables, our standards for Hematology, the ASH Education Program have never been higher, and we hope you will find that the quality of the content has never been better. We are also happy to say to all the bookworms out there that your pleas have been heard: the print version of Hematology is now once again available, this time for sale on an opt-in basis. This way, everyone wins: those who prefer to read the content online can continue to do so, and those who prefer a physical book can buy one if they wish. Best of all, no one needs to find room in their luggage for the tome, as preordered printed copies will be shipped soon after the meeting. In this volume, you will find articles for every session included in the education program, as well as a series of thought-provoking evidence-based minireviews, all written by international expert speaker-authors.

We must thank this year’s education co-chairs, Dr. Jean Connors (classical hematology) and Dr. Amy DeZern (malignant hematology), for crafting a state-of-the-art education program on which this volume is based. Finally, Hematology is possible only thanks to the efforts of hundreds of invaluable peer reviewers and the diligent efforts of the ASH publications staff, including Ebony Stewart, Alison Beale, Jeremiah Murphy, Dax Rodulfa-Blemberg, Brian Cannon, Kenneth April, Keith Gigliello, Glenn Landis, and Nina Hoffman, among others. We are thankful for all of their work.

Happy reading, from your Hematology editors!

Editors

Hanny Al-Samkari, MD, Executive Editor, is an assistant professor of medicine at Harvard Medical School and practices adult classical hematology at the Massachusetts General Hospital, where he directs the Massachusetts General Hospital Hereditary Hemorrhagic Telangiectasia Center of Excellence. His research focuses on the development of novel therapeutics in hereditary hemorrhagic telangiectasia, platelet disorders, and congenital red cell disorders.

Alison R. Walker, MD, MPH, MBA, Deputy Editor, is a professor of oncologic sciences at the University of South Florida and a member of the Department of Malignant Hematology at H. Lee Moffitt Cancer Center & Research Institute, where she serves as a physician practice advisor to the Moffitt Medical Group. Dr. Walker’s clinical and research interests are in the care of patients with myeloid malignancies, specifically acute myeloid leukemia and myelodysplastic syndromes.

Rakhi P. Naik, MD, MHS, Deputy Editor, is an associate professor of medicine at Johns Hopkins University, where she serves as clinical director of the Division of Hematology and associate program director for the Hematology Fellowship Track. Dr. Naik’s research focuses on sickle cell disease, sickle cell trait, and medical education innovation.

Alex F. Herrera, MD, Deputy Editor, is an associate professor in the Department of Hematology and Hematopoietic Cell Transplantation at City of Hope in Duarte, California. His clinical and research interests center on immunotherapy and hematopoietic stem cell transplantation in patients with Hodgkin or non-Hodgkin lymphomas. He also studies biomarkers of response and outcome in patients with lymphoma treated with immunotherapies or hematopoietic stem cell transplantation with the goal of designing biomarker-based clinical trials to improve outcomes and personalize lymphoma treatment.

Ang Li, MD, MS, Special Section Editor, is an assistant professor at Baylor College of Medicine, a member of the Dan L Duncan Comprehensive Cancer Center, and a Cancer Prevention & Research Institute of Texas (CPRIT) Scholar. Clinically, he specializes in the care of patients with thrombotic and bleeding disorders. As a physician-scientist, he focuses on the epidemiology, prevention, and treatment of venous thromboembolism and thrombotic microangiopathy in association with cancer treatment and hematopoietic cell transplantation.